Clinical Trial Update: Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine [NA]

View source ↗

Summary

Clinical trial comparing sodium bicarbonate to sodium chloride and N-acetylcysteine for preventing contrast-induced nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Sodium Bicarbonate (sodium bicarbonate)
• Sodium Chloride (Sodium chloride)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Acute Renal Failure Contrast Nephropathy | NA | Status: COMPLETED